Bone density-related predictors of blood lead level among peri- and postmenopausal women in the United States - The Third National Health and Nutrition Examination Survey, 1988-1994

被引:80
作者
Nash, D
Magder, LS
Sherwin, R
Rubin, RJ
Silbergeld, EK
机构
[1] New York Acad Med, Ctr Urban Epidemiol Studies, New York, NY 10029 USA
[2] Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA
[3] Tulane Univ, Sch Publ Hlth, Dept Epidemiol, New Orleans, LA USA
[4] Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA
关键词
bone density; bone resorption; hormone replacement therapy; lead; menopause; women;
D O I
10.1093/aje/kwh296
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Because of the long half-life of lead stored in bone (years), skeletal lead stores may be a source of endogenous lead exposure during periods of increased bone demineralization, such as menopause. To test the hypothesis that postmenopausal bone resorption increases blood lead levels, the authors examined cross-sectional associations of bone density-related factors with blood lead levels among women aged 40-59 years from the Third National Health and Nutrition Examination Survey (1988-1994). Factors related to bone turnover were significant predictors of blood lead level. Bone mineral density was significantly inversely related to blood lead levels in log-linear multivariate models that adjusted for age, race/ethnicity, smoking, education, household income, alcohol use, and residence (urban/rural). With menopausal status added to the model, naturally and surgically menopausal women had adjusted median blood lead levels that were 25% and 30% higher, respectively, than those of premenopausal women (2.0 mug/dl). Current use of hormone replacement therapy was associated with significantly lower adjusted median blood lead levels (1.8 mug/dl) than past use (2.6 mug/dl) and never use (2.2 mug/dl). Lead stored in bone may significantly increase blood lead levels in perimenopausal women because of postmenopausal bone mineral resorption. Attention to factors that prevent bone loss may lessen or prevent this endogenous lead exposure.
引用
收藏
页码:901 / 911
页数:11
相关论文
共 81 条
  • [1] Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures:: the PERF study
    Bagger, YZ
    Tankó, LB
    Alexandersen, P
    Hansen, HB
    Mollgaard, A
    Ravn, P
    Qvist, P
    Kanis, JA
    Christiansen, C
    [J]. BONE, 2004, 34 (04) : 728 - 735
  • [2] THE EFFECT OF HIGH-LEVEL PHYSICAL-ACTIVITY (8.5 METS OR GREATER) AND ESTROGEN REPLACEMENT THERAPY UPON BONE MASS IN POSTMENOPAUSAL FEMALES, AGED 50-68 YEARS
    BALLARD, JE
    MCKEOWN, BC
    GRAHAM, HM
    ZINKGRAF, SA
    [J]. INTERNATIONAL JOURNAL OF SPORTS MEDICINE, 1990, 11 (03) : 208 - 214
  • [3] Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study
    Barrett-Connor, E
    Wehren, LE
    Siris, ES
    Miller, P
    Chen, YT
    Abbott, TA
    Berger, ML
    Santora, AC
    Sherwood, LM
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2003, 10 (05): : 412 - 419
  • [4] POSTMENOPAUSAL ESTROGEN AND PREVENTION BIAS
    BARRETTCONNOR, E
    [J]. ANNALS OF INTERNAL MEDICINE, 1991, 115 (06) : 455 - 456
  • [5] BARRY PSI, 1970, BRIT J IND MED, V27, P339
  • [6] Metal-bone interactions
    Berglund, M
    Åkesson, A
    Bjellerup, P
    Vahter, M
    [J]. TOXICOLOGY LETTERS, 2000, 112 : 219 - 225
  • [7] Borjesson J, 1997, INT ARCH OCC ENV HEA, V69, P97
  • [8] BLOOD LEAD LEVELS IN THE US POPULATION - PHASE-1 OF THE 3RD NATIONAL-HEALTH AND NUTRITION EXAMINATION SURVEY (NHANES-III, 1988 TO 1991)
    BRODY, DJ
    PIRKLE, JL
    KRAMER, RA
    FLEGAL, KM
    MATTE, TD
    GUNTER, EW
    PASCHAL, DC
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (04): : 277 - 283
  • [9] BRONNER F, 1992, NEUROTOXICOLOGY, V13, P775
  • [10] Effects of hormone therapy on bone mineral density - Results from the postmenopausal estrogen/progestin interventions (PEPI) trial
    Bush, TL
    Wells, HB
    James, MK
    BarrettConnor, E
    Marcus, R
    Greendale, G
    Hunsberger, S
    McGowan, J
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (17): : 1389 - 1396